Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2213 | 2246 | 37.7 | 59% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
395 | 16247 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYP2C12 | Author keyword | 12 | 86% | 0% | 6 |
2 | ONE DAY TREATMENT | Author keyword | 12 | 86% | 0% | 6 |
3 | S BIOCHEM | Address | 9 | 36% | 1% | 20 |
4 | 2 METHOXY 4 NITROANILINE | Author keyword | 6 | 80% | 0% | 4 |
5 | AROCHLOR 1254 | Author keyword | 6 | 80% | 0% | 4 |
6 | CYP2C11 | Author keyword | 5 | 27% | 1% | 15 |
7 | CYP2C7 | Author keyword | 4 | 67% | 0% | 4 |
8 | LIVER CYTOCHROME P450 | Author keyword | 4 | 75% | 0% | 3 |
9 | CYP3A41 | Author keyword | 3 | 100% | 0% | 3 |
10 | CYP3A9 | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYP2C12 | 12 | 86% | 0% | 6 | Search CYP2C12 | Search CYP2C12 |
2 | ONE DAY TREATMENT | 12 | 86% | 0% | 6 | Search ONE+DAY+TREATMENT | Search ONE+DAY+TREATMENT |
3 | 2 METHOXY 4 NITROANILINE | 6 | 80% | 0% | 4 | Search 2+METHOXY+4+NITROANILINE | Search 2+METHOXY+4+NITROANILINE |
4 | AROCHLOR 1254 | 6 | 80% | 0% | 4 | Search AROCHLOR+1254 | Search AROCHLOR+1254 |
5 | CYP2C11 | 5 | 27% | 1% | 15 | Search CYP2C11 | Search CYP2C11 |
6 | CYP2C7 | 4 | 67% | 0% | 4 | Search CYP2C7 | Search CYP2C7 |
7 | LIVER CYTOCHROME P450 | 4 | 75% | 0% | 3 | Search LIVER+CYTOCHROME+P450 | Search LIVER+CYTOCHROME+P450 |
8 | CYP3A41 | 3 | 100% | 0% | 3 | Search CYP3A41 | Search CYP3A41 |
9 | CYP3A9 | 3 | 100% | 0% | 3 | Search CYP3A9 | Search CYP3A9 |
10 | DRUG METABOLISM MURINE | 3 | 100% | 0% | 3 | Search DRUG+METABOLISM++MURINE | Search DRUG+METABOLISM++MURINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PITUITARY REGULATION | 36 | 77% | 1% | 24 |
2 | SEX DEPENDENT FORMS | 33 | 100% | 1% | 13 |
3 | P 450 HFLA | 21 | 85% | 0% | 11 |
4 | SEX SPECIFIC FORMS | 17 | 63% | 1% | 17 |
5 | REGULATING EXPRESSION | 17 | 70% | 1% | 14 |
6 | STEROID 16 ALPHA HYDROXYLASE | 14 | 64% | 1% | 14 |
7 | HIGH SPIN FORM | 13 | 80% | 0% | 8 |
8 | BRAIN DOPAMINERGIC SYSTEM | 12 | 86% | 0% | 6 |
9 | HEPATIC CYTOCHROME P 450 | 10 | 18% | 2% | 50 |
10 | P 450 FORMS | 9 | 64% | 0% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
THE P450 SUPERFAMILY - UPDATE ON NEW SEQUENCES, GENE-MAPPING, ACCESSION NUMBERS, EARLY TRIVIAL NAMES OF ENZYMES, AND NOMENCLATURE | 1993 | 1394 | 547 | 38% |
GENDER DIFFERENCES IN DRUG-METABOLISM REGULATED BY GROWTH-HORMONE | 1995 | 145 | 43 | 81% |
PHENOBARBITAL INDUCTION OF CYTOCHROME-P-450 GENE-EXPRESSION | 1992 | 491 | 195 | 48% |
THE P450 SUPERFAMILY - UPDATED LISTING OF ALL GENES AND RECOMMENDED NOMENCLATURE FOR THE CHROMOSOMAL LOCI | 1989 | 558 | 131 | 51% |
P450 GENES - STRUCTURE, EVOLUTION, AND REGULATION | 1987 | 1309 | 232 | 39% |
PURIFICATION AND CHARACTERIZATION OF HEPATIC-MICROSOMAL CYTOCHROME-P-450 | 1990 | 418 | 385 | 62% |
MOLECULAR-GENETICS OF THE P-450 SUPERFAMILY | 1990 | 478 | 303 | 40% |
Growth hormone regulation of sex-dependent liver gene expression | 2006 | 173 | 109 | 26% |
CYTOCHROMES P-450 IN RATS - STRUCTURES, FUNCTIONS, PROPERTIES AND RELEVANT HUMAN FORMS | 1992 | 202 | 154 | 53% |
ENZYME-INDUCTION IN THE CYTOCHROME-P-450 SYSTEM | 1990 | 596 | 217 | 26% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | S BIOCHEM | 9 | 36% | 0.9% | 20 |
2 | PMNT | 1 | 50% | 0.1% | 2 |
3 | MOL PATHOL ECOL BIOCHEM | 1 | 27% | 0.2% | 4 |
4 | PHARMACOGENOM DRUG DEV GRP | 1 | 20% | 0.2% | 4 |
5 | BASIC CLIN BIOCHEM | 1 | 50% | 0.0% | 1 |
6 | BIOCHEM MOL EXPT MED | 1 | 50% | 0.0% | 1 |
7 | CNRS URA 147 PHARMACOTOXICOL PHARMACOGENET | 1 | 50% | 0.0% | 1 |
8 | LIVER PATHOBIOL GRP | 1 | 50% | 0.0% | 1 |
9 | DRUG METABKITA KU | 0 | 20% | 0.1% | 2 |
10 | DRUG DISPOSIT SAFETY | 0 | 33% | 0.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000214818 | PHARMACOKINET BIOANAL//CYP2D19//PROPRANOLOL ENANTIOMER |
2 | 0.0000154183 | N ALKYLPROTOPORPHYRIN IX//1 AMINOBENZOTRIAZOLE//CHICK EMBRYO LIVER |
3 | 0.0000134177 | ANTLEY BIXLER SYNDROME//CYTOCHROME P450 OXIDOREDUCTASE//NADPH CYTOCHROME P450 REDUCTASE |
4 | 0.0000132825 | MARIE LOWE COMPARAT ONCOL//CYP2D//MARI LOWE COMPARAT ONCOL |
5 | 0.0000121663 | CYP2E1//CHLORZOXAZONE//6 HYDROXYCHLORZOXAZONE |
6 | 0.0000106798 | PREGNANE X RECEPTOR//PXR//CONSTITUTIVE ANDROSTANE RECEPTOR |
7 | 0.0000086832 | GV TB//RECONSTRUCTED HUMAN SKIN MODELS//DIP FARMACOBIOL |
8 | 0.0000084433 | MICROSOMAL FATTY ACID COMPOSITION//CYTOCHROME P 4501A2//CYTOCHROME P 4501A1 |
9 | 0.0000082744 | O AMINOAZOTOLUENE//GLUCOCORTICOID INDUCTION//ORTHO AMINOAZOTOLUENE |
10 | 0.0000080965 | CYP2A6//CYP2A5//CYP2A13 |